Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brachytherapy | 60 | 2022 | 1248 | 6.600 |
Why?
|
Radiation Oncology | 7 | 2022 | 555 | 1.490 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 14 | 2021 | 1624 | 1.260 |
Why?
|
Radiotherapy Dosage | 31 | 2022 | 2879 | 1.200 |
Why?
|
Mycosis Fungoides | 4 | 2023 | 163 | 0.900 |
Why?
|
Carcinoma, Squamous Cell | 8 | 2020 | 4034 | 0.820 |
Why?
|
Skin Neoplasms | 14 | 2023 | 5686 | 0.780 |
Why?
|
Organs at Risk | 4 | 2019 | 346 | 0.750 |
Why?
|
Radiotherapy | 4 | 2019 | 1533 | 0.740 |
Why?
|
Iodine Radioisotopes | 6 | 2014 | 1032 | 0.730 |
Why?
|
Penile Neoplasms | 1 | 2020 | 160 | 0.650 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2022 | 9239 | 0.600 |
Why?
|
Carcinoma, Basal Cell | 2 | 2019 | 545 | 0.570 |
Why?
|
Radiation Injuries | 7 | 2021 | 1180 | 0.570 |
Why?
|
Meningioma | 3 | 2022 | 1209 | 0.560 |
Why?
|
Salvage Therapy | 3 | 2022 | 1275 | 0.550 |
Why?
|
Meningeal Neoplasms | 3 | 2022 | 1241 | 0.550 |
Why?
|
Coronary Restenosis | 2 | 2017 | 424 | 0.530 |
Why?
|
Graft Occlusion, Vascular | 2 | 2017 | 549 | 0.510 |
Why?
|
Mediastinal Neoplasms | 2 | 2008 | 423 | 0.490 |
Why?
|
Prostatic Neoplasms | 13 | 2019 | 11124 | 0.470 |
Why?
|
Neurosurgery | 1 | 2019 | 643 | 0.450 |
Why?
|
Radiometry | 4 | 2012 | 800 | 0.440 |
Why?
|
Facial Neoplasms | 1 | 2013 | 121 | 0.410 |
Why?
|
Carcinoma, Merkel Cell | 4 | 2022 | 300 | 0.390 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 753 | 0.370 |
Why?
|
Dermatology | 1 | 2020 | 872 | 0.350 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4253 | 0.340 |
Why?
|
Carcinoid Tumor | 2 | 2009 | 235 | 0.330 |
Why?
|
Quinuclidines | 1 | 2008 | 24 | 0.330 |
Why?
|
Serotonin Antagonists | 1 | 2008 | 144 | 0.320 |
Why?
|
Sarcoma | 6 | 2014 | 1897 | 0.300 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.300 |
Why?
|
Radiotherapy, Adjuvant | 7 | 2019 | 1770 | 0.300 |
Why?
|
Hepatic Artery | 1 | 2008 | 245 | 0.300 |
Why?
|
Thoracic Neoplasms | 1 | 2009 | 268 | 0.290 |
Why?
|
Isoquinolines | 1 | 2008 | 367 | 0.290 |
Why?
|
Radiotherapy, Conformal | 1 | 2010 | 548 | 0.280 |
Why?
|
Breast Neoplasms | 8 | 2020 | 20822 | 0.270 |
Why?
|
Smallpox | 1 | 2005 | 45 | 0.260 |
Why?
|
Nausea | 1 | 2008 | 673 | 0.260 |
Why?
|
Vomiting | 1 | 2008 | 636 | 0.260 |
Why?
|
Smallpox Vaccine | 1 | 2005 | 80 | 0.250 |
Why?
|
Societies, Medical | 6 | 2022 | 3743 | 0.250 |
Why?
|
Health Care Surveys | 1 | 2012 | 2453 | 0.250 |
Why?
|
Prostate-Specific Antigen | 2 | 2017 | 2494 | 0.250 |
Why?
|
Embolization, Therapeutic | 2 | 2019 | 1392 | 0.250 |
Why?
|
Dose-Response Relationship, Radiation | 5 | 2017 | 876 | 0.240 |
Why?
|
Head and Neck Neoplasms | 2 | 2011 | 2734 | 0.230 |
Why?
|
Breast | 2 | 2008 | 1969 | 0.210 |
Why?
|
Rectum | 5 | 2017 | 904 | 0.210 |
Why?
|
Humans | 81 | 2023 | 744343 | 0.210 |
Why?
|
Aged | 36 | 2020 | 163280 | 0.210 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2212 | 0.200 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2021 | 9 | 0.200 |
Why?
|
Treatment Outcome | 23 | 2020 | 63114 | 0.200 |
Why?
|
Paget Disease, Extramammary | 1 | 2021 | 45 | 0.190 |
Why?
|
Genital Neoplasms, Male | 1 | 2021 | 74 | 0.190 |
Why?
|
Survival Rate | 7 | 2019 | 12788 | 0.190 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2019 | 207 | 0.180 |
Why?
|
Combined Modality Therapy | 7 | 2019 | 8642 | 0.170 |
Why?
|
Early Detection of Cancer | 1 | 2013 | 3086 | 0.170 |
Why?
|
Aged, 80 and over | 17 | 2020 | 57776 | 0.170 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 169 | 0.170 |
Why?
|
Cicatrix | 1 | 2005 | 764 | 0.170 |
Why?
|
Internet | 2 | 2020 | 3064 | 0.170 |
Why?
|
Androgen Antagonists | 2 | 2017 | 1377 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 8 | 2021 | 20129 | 0.160 |
Why?
|
Middle Aged | 34 | 2020 | 213383 | 0.160 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2018 | 71 | 0.160 |
Why?
|
Mammography | 2 | 2010 | 2476 | 0.160 |
Why?
|
Nuclear Medicine | 1 | 2021 | 233 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11524 | 0.160 |
Why?
|
Male | 41 | 2021 | 350118 | 0.150 |
Why?
|
Patient Selection | 3 | 2019 | 4215 | 0.150 |
Why?
|
Consumer Health Information | 1 | 2020 | 211 | 0.150 |
Why?
|
SEER Program | 2 | 2020 | 1508 | 0.150 |
Why?
|
Acrodermatitis | 1 | 2017 | 18 | 0.150 |
Why?
|
Skin | 4 | 2020 | 4364 | 0.150 |
Why?
|
Carcinoma | 1 | 2009 | 2375 | 0.150 |
Why?
|
Adenocarcinoma | 4 | 2016 | 6364 | 0.150 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.140 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2016 | 68 | 0.140 |
Why?
|
Yttrium Radioisotopes | 3 | 2021 | 93 | 0.140 |
Why?
|
Foot Dermatoses | 1 | 2016 | 44 | 0.140 |
Why?
|
Hand Dermatoses | 1 | 2016 | 61 | 0.140 |
Why?
|
Radiotherapy, Computer-Assisted | 4 | 2010 | 94 | 0.130 |
Why?
|
Female | 36 | 2022 | 380194 | 0.130 |
Why?
|
Soft Tissue Neoplasms | 2 | 2012 | 1363 | 0.130 |
Why?
|
Consensus | 2 | 2015 | 2959 | 0.130 |
Why?
|
Databases, Factual | 5 | 2019 | 7729 | 0.130 |
Why?
|
Comprehension | 1 | 2020 | 610 | 0.130 |
Why?
|
Software Validation | 1 | 2014 | 59 | 0.120 |
Why?
|
Retrospective Studies | 17 | 2022 | 77449 | 0.120 |
Why?
|
Postoperative Period | 1 | 2020 | 1842 | 0.120 |
Why?
|
Survival Analysis | 5 | 2017 | 10252 | 0.120 |
Why?
|
Mammaplasty | 1 | 2005 | 1204 | 0.120 |
Why?
|
Popliteal Artery | 1 | 2016 | 317 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2017 | 2020 | 0.120 |
Why?
|
Intermittent Claudication | 1 | 2016 | 309 | 0.120 |
Why?
|
Genital Neoplasms, Female | 2 | 2009 | 523 | 0.120 |
Why?
|
United States | 10 | 2022 | 69872 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2009 | 5221 | 0.110 |
Why?
|
Hidradenitis Suppurativa | 1 | 2016 | 153 | 0.110 |
Why?
|
Fluorouracil | 2 | 2011 | 1619 | 0.110 |
Why?
|
Extremities | 2 | 2017 | 865 | 0.110 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 653 | 0.110 |
Why?
|
Femoral Artery | 1 | 2016 | 845 | 0.110 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39050 | 0.100 |
Why?
|
Cisplatin | 2 | 2011 | 1662 | 0.100 |
Why?
|
Models, Biological | 1 | 2008 | 9583 | 0.100 |
Why?
|
Erythema | 1 | 2013 | 257 | 0.100 |
Why?
|
Iridium Radioisotopes | 3 | 2009 | 26 | 0.100 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1838 | 0.100 |
Why?
|
Lower Extremity | 2 | 2016 | 1158 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1065 | 0.100 |
Why?
|
Film Dosimetry | 2 | 2017 | 29 | 0.090 |
Why?
|
Time Factors | 6 | 2017 | 40075 | 0.090 |
Why?
|
Prosthesis Design | 1 | 2017 | 2110 | 0.090 |
Why?
|
Feasibility Studies | 4 | 2021 | 5078 | 0.090 |
Why?
|
Radiobiology | 1 | 2010 | 85 | 0.090 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2013 | 340 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6538 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1486 | 0.080 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2013 | 604 | 0.080 |
Why?
|
Radiation Protection | 1 | 2012 | 419 | 0.080 |
Why?
|
Mastectomy | 2 | 2008 | 1793 | 0.080 |
Why?
|
Mediastinum | 1 | 2009 | 267 | 0.080 |
Why?
|
Psoriasis | 1 | 2016 | 898 | 0.080 |
Why?
|
Carboplatin | 1 | 2011 | 801 | 0.080 |
Why?
|
Ischemia | 1 | 2016 | 1907 | 0.080 |
Why?
|
Strontium Radioisotopes | 2 | 2004 | 18 | 0.080 |
Why?
|
Taxoids | 1 | 2011 | 666 | 0.080 |
Why?
|
Technology, Radiologic | 1 | 2007 | 163 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2214 | 0.070 |
Why?
|
Adult | 18 | 2019 | 214055 | 0.070 |
Why?
|
Prospective Studies | 9 | 2021 | 53288 | 0.070 |
Why?
|
Organizational Objectives | 1 | 2008 | 438 | 0.070 |
Why?
|
Polyethylene Glycols | 1 | 2012 | 1182 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2017 | 3479 | 0.070 |
Why?
|
Rectal Diseases | 1 | 2007 | 143 | 0.070 |
Why?
|
Prevotella melaninogenica | 1 | 2005 | 13 | 0.070 |
Why?
|
Streptococcus mitis | 1 | 2005 | 8 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.070 |
Why?
|
Capnocytophaga | 1 | 2005 | 26 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2006 | 106 | 0.070 |
Why?
|
Medical Oncology | 1 | 2017 | 2265 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6365 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2017 | 3107 | 0.070 |
Why?
|
Hepatectomy | 1 | 2009 | 550 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 9959 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2017 | 4577 | 0.060 |
Why?
|
History, 18th Century | 1 | 2005 | 214 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 477 | 0.060 |
Why?
|
Organizational Culture | 1 | 2008 | 510 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3280 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2017 | 2657 | 0.060 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 973 | 0.060 |
Why?
|
Neoplasm Staging | 5 | 2019 | 11031 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.060 |
Why?
|
Tongue Neoplasms | 1 | 2005 | 180 | 0.060 |
Why?
|
Palliative Care | 2 | 2015 | 3493 | 0.060 |
Why?
|
Radiation Dosage | 3 | 2017 | 1928 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2012 | 1333 | 0.060 |
Why?
|
History, 19th Century | 1 | 2005 | 720 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7279 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15540 | 0.050 |
Why?
|
Leucovorin | 1 | 2004 | 628 | 0.050 |
Why?
|
Therapy, Computer-Assisted | 1 | 2005 | 274 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4851 | 0.050 |
Why?
|
Mass Media | 1 | 2005 | 305 | 0.050 |
Why?
|
Colon, Sigmoid | 2 | 2017 | 120 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Risk Factors | 5 | 2019 | 72290 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2266 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4567 | 0.050 |
Why?
|
Public Opinion | 1 | 2005 | 477 | 0.050 |
Why?
|
Propensity Score | 2 | 2019 | 1781 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2014 | 15295 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5985 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2008 | 1406 | 0.050 |
Why?
|
Saliva | 1 | 2005 | 809 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2008 | 1101 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2014 | 19905 | 0.050 |
Why?
|
Phototherapy | 1 | 2023 | 377 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2007 | 1130 | 0.050 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2002 | 358 | 0.050 |
Why?
|
Therapeutics | 1 | 2020 | 116 | 0.040 |
Why?
|
Mouth Neoplasms | 1 | 2005 | 601 | 0.040 |
Why?
|
Suicide, Attempted | 1 | 2008 | 1221 | 0.040 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6895 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2019 | 342 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2002 | 297 | 0.040 |
Why?
|
Tumor Burden | 2 | 2016 | 1915 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14722 | 0.040 |
Why?
|
Adolescent | 7 | 2019 | 85781 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 35421 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2015 | 13102 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2002 | 826 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 7913 | 0.040 |
Why?
|
Prostate | 2 | 2017 | 1774 | 0.040 |
Why?
|
History, 20th Century | 1 | 2005 | 2740 | 0.040 |
Why?
|
Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6487 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2008 | 3474 | 0.040 |
Why?
|
Endometrial Neoplasms | 1 | 2006 | 1353 | 0.040 |
Why?
|
Catheters | 1 | 2020 | 425 | 0.040 |
Why?
|
Medical Records | 1 | 2002 | 1413 | 0.040 |
Why?
|
Young Adult | 5 | 2019 | 56430 | 0.030 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2013 | 806 | 0.030 |
Why?
|
Urinary Bladder | 2 | 2017 | 1172 | 0.030 |
Why?
|
Skin Transplantation | 2 | 2012 | 1074 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2016 | 205 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3616 | 0.030 |
Why?
|
Prognosis | 4 | 2018 | 29063 | 0.030 |
Why?
|
Heart | 1 | 2008 | 4467 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2002 | 1431 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 610 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6196 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1769 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1692 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13695 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12354 | 0.030 |
Why?
|
Bacteria | 1 | 2005 | 2114 | 0.030 |
Why?
|
Vascular Patency | 1 | 2016 | 886 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2021 | 828 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 455 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 1107 | 0.030 |
Why?
|
Electroencephalography | 1 | 2008 | 6150 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1254 | 0.030 |
Why?
|
Respiratory-Gated Imaging Techniques | 1 | 2012 | 71 | 0.030 |
Why?
|
Neoadjuvant Therapy | 2 | 2013 | 2728 | 0.030 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2012 | 145 | 0.020 |
Why?
|
Swine | 1 | 2021 | 5917 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.020 |
Why?
|
Risk Assessment | 2 | 2013 | 23338 | 0.020 |
Why?
|
Sampling Studies | 1 | 2012 | 623 | 0.020 |
Why?
|
Angiography | 1 | 2016 | 1639 | 0.020 |
Why?
|
Language | 1 | 2020 | 1471 | 0.020 |
Why?
|
Water | 1 | 2017 | 1395 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7799 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2008 | 4644 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2014 | 492 | 0.020 |
Why?
|
Lung | 1 | 2008 | 9856 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.020 |
Why?
|
Cesium Radioisotopes | 1 | 2009 | 36 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2012 | 402 | 0.020 |
Why?
|
Safety | 1 | 2014 | 1186 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1989 | 2540 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2480 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1989 | 113 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2013 | 956 | 0.020 |
Why?
|
Software | 1 | 2002 | 4443 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 648 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 13881 | 0.020 |
Why?
|
Palladium | 1 | 2007 | 65 | 0.020 |
Why?
|
Hydrogels | 1 | 2012 | 724 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2386 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2012 | 1359 | 0.020 |
Why?
|
Radioisotopes | 1 | 2007 | 499 | 0.020 |
Why?
|
Leg | 1 | 2010 | 1116 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
Genes | 1 | 1988 | 1893 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2012 | 1640 | 0.010 |
Why?
|
Critical Illness | 1 | 2016 | 2670 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Beta Particles | 1 | 2003 | 50 | 0.010 |
Why?
|
Preoperative Care | 1 | 2012 | 2250 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5952 | 0.010 |
Why?
|
Smoking | 2 | 2013 | 8987 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3582 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12959 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2785 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1953 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
Brain | 1 | 2008 | 26385 | 0.010 |
Why?
|
Functional Laterality | 1 | 2008 | 2290 | 0.010 |
Why?
|
ROC Curve | 1 | 2008 | 3527 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4982 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2004 | 834 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7186 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7474 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2005 | 1401 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6234 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10943 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2003 | 1161 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 2289 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4933 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8324 | 0.010 |
Why?
|
Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 12804 | 0.010 |
Why?
|
Piperazines | 1 | 2003 | 2488 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 7023 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 40561 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1988 | 10180 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168757 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1989 | 878 | 0.000 |
Why?
|
Blotting, Southern | 1 | 1989 | 803 | 0.000 |
Why?
|
Base Sequence | 2 | 1989 | 12797 | 0.000 |
Why?
|
Amino Acid Sequence | 2 | 1989 | 13815 | 0.000 |
Why?
|
Molecular Sequence Data | 2 | 1989 | 18111 | 0.000 |
Why?
|
Cell Line | 2 | 1989 | 15997 | 0.000 |
Why?
|
Thymus Gland | 1 | 1989 | 1267 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1989 | 13033 | 0.000 |
Why?
|
Genetic Variation | 1 | 1988 | 6544 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1989 | 25625 | 0.000 |
Why?
|